Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

One-Dimensional Arsenic Allotropes: Polymerization of Yellow Arsenic Inside Single-Wall Carbon Nanotubes.

Hart M, Chen J, Michaelides A, Sella A, Shaffer MSP, Salzmann CG.

Angew Chem Int Ed Engl. 2018 Sep 3;57(36):11649-11653. doi: 10.1002/anie.201805856. Epub 2018 Aug 6.

PMID:
30025181
2.

The deterministic role of 5-mers in microRNA-gene targeting.

Hart M, Kern F, Backes C, Rheinheimer S, Fehlmann T, Keller A, Meese E.

RNA Biol. 2018;15(6):819-825. doi: 10.1080/15476286.2018.1462652. Epub 2018 May 11.

PMID:
29749304
3.

A high-resolution map of the human small non-coding transcriptome.

Fehlmann T, Backes C, Alles J, Fischer U, Hart M, Kern F, Langseth H, Rounge T, Umu SU, Kahraman M, Laufer T, Haas J, Staehler C, Ludwig N, Hübenthal M, Meder B, Franke A, Lenhof HP, Meese E, Keller A.

Bioinformatics. 2018 May 15;34(10):1621-1628. doi: 10.1093/bioinformatics/btx814.

PMID:
29281000
4.

Encapsulation and Polymerization of White Phosphorus Inside Single-Wall Carbon Nanotubes.

Hart M, White ER, Chen J, McGilvery CM, Pickard CJ, Michaelides A, Sella A, Shaffer MSP, Salzmann CG.

Angew Chem Int Ed Engl. 2017 Jul 3;56(28):8144-8148. doi: 10.1002/anie.201703585. Epub 2017 Jun 12.

5.

MiR-34a-3p alters proliferation and apoptosis of meningioma cells in vitro and is directly targeting SMAD4, FRAT1 and BCL2.

Werner TV, Hart M, Nickels R, Kim YJ, Menger MD, Bohle RM, Keller A, Ludwig N, Meese E.

Aging (Albany NY). 2017 Mar 23;9(3):932-954. doi: 10.18632/aging.101201.

6.

Analysis of Argonaute Complex Bound mRNAs in DU145 Prostate Carcinoma Cells Reveals New miRNA Target Genes.

Szczyrba J, Jung V, Beitzinger M, Nolte E, Wach S, Hart M, Sapich S, Wiesehöfer M, Taubert H, Wennemuth G, Eichner N, Stempfl T, Wullich B, Meister G, Grässer FA.

Prostate Cancer. 2017;2017:4893921. doi: 10.1155/2017/4893921. Epub 2017 Jan 5.

7.

cPAS-based sequencing on the BGISEQ-500 to explore small non-coding RNAs.

Fehlmann T, Reinheimer S, Geng C, Su X, Drmanac S, Alexeev A, Zhang C, Backes C, Ludwig N, Hart M, An D, Zhu Z, Xu C, Chen A, Ni M, Liu J, Li Y, Poulter M, Li Y, Stähler C, Drmanac R, Xu X, Meese E, Keller A.

Clin Epigenetics. 2016 Nov 21;8:123. eCollection 2016.

8.

Altered micro-ribonucleic acid expression profiles of extracellular microvesicles in the seminal plasma of patients with oligoasthenozoospermia.

Abu-Halima M, Ludwig N, Hart M, Leidinger P, Backes C, Keller A, Hammadeh M, Meese E.

Fertil Steril. 2016 Oct;106(5):1061-1069.e3. doi: 10.1016/j.fertnstert.2016.06.030. Epub 2016 Jul 14.

PMID:
27424049
9.

miRNA expression profiling of Epstein-Barr virus-associated NKTL cell lines by Illumina deep sequencing.

Alles J, Menegatti J, Motsch N, Hart M, Eichner N, Reinhardt R, Meister G, Grässer FA.

FEBS Open Bio. 2016 Feb 27;6(4):251-63. doi: 10.1002/2211-5463.12027. eCollection 2016 Apr.

10.

Identification of miR-34a-target interactions by a combined network based and experimental approach.

Hart M, Rheinheimer S, Leidinger P, Backes C, Menegatti J, Fehlmann T, Grässer F, Keller A, Meese E.

Oncotarget. 2016 Jun 7;7(23):34288-99. doi: 10.18632/oncotarget.9103.

11.

MiRTargetLink--miRNAs, Genes and Interaction Networks.

Hamberg M, Backes C, Fehlmann T, Hart M, Meder B, Meese E, Keller A.

Int J Mol Sci. 2016 Apr 14;17(4):564. doi: 10.3390/ijms17040564.

12.

Deep characterization of blood cell miRNomes by NGS.

Schwarz EC, Backes C, Knörck A, Ludwig N, Leidinger P, Hoxha C, Schwär G, Grossmann T, Müller SC, Hart M, Haas J, Galata V, Müller I, Fehlmann T, Eichler H, Franke A, Meder B, Meese E, Hoth M, Keller A.

Cell Mol Life Sci. 2016 Aug;73(16):3169-81. doi: 10.1007/s00018-016-2154-9. Epub 2016 Feb 13.

PMID:
26874686
13.

Differential blood-based diagnosis between benign prostatic hyperplasia and prostate cancer: miRNA as source for biomarkers independent of PSA level, Gleason score, or TNM status.

Leidinger P, Hart M, Backes C, Rheinheimer S, Keck B, Wullich B, Keller A, Meese E.

Tumour Biol. 2016 Aug;37(8):10177-85. doi: 10.1007/s13277-016-4883-7. Epub 2016 Jan 29.

PMID:
26831660
14.

Bias in High-Throughput Analysis of miRNAs and Implications for Biomarker Studies.

Backes C, Sedaghat-Hamedani F, Frese K, Hart M, Ludwig N, Meder B, Meese E, Keller A.

Anal Chem. 2016 Feb 16;88(4):2088-95. doi: 10.1021/acs.analchem.5b03376. Epub 2016 Jan 27.

PMID:
26760198
15.

Prioritizing and selecting likely novel miRNAs from NGS data.

Backes C, Meder B, Hart M, Ludwig N, Leidinger P, Vogel B, Galata V, Roth P, Menegatti J, Grässer F, Ruprecht K, Kahraman M, Grossmann T, Haas J, Meese E, Keller A.

Nucleic Acids Res. 2016 Apr 7;44(6):e53. doi: 10.1093/nar/gkv1335. Epub 2015 Dec 3.

16.

Combination of Autoantibody Signature with PSA Level Enables a Highly Accurate Blood-Based Differentiation of Prostate Cancer Patients from Patients with Benign Prostatic Hyperplasia.

Leidinger P, Keller A, Milchram L, Harz C, Hart M, Werth A, Lenhof HP, Weinhäusel A, Keck B, Wullich B, Ludwig N, Meese E.

PLoS One. 2015 Jun 3;10(6):e0128235. doi: 10.1371/journal.pone.0128235. eCollection 2015.

17.

Blood born miRNAs signatures that can serve as disease specific biomarkers are not significantly affected by overall fitness and exercise.

Backes C, Leidinger P, Keller A, Hart M, Meyer T, Meese E, Hecksteden A.

PLoS One. 2014 Jul 10;9(7):e102183. doi: 10.1371/journal.pone.0102183. eCollection 2014.

18.

Comparative microRNA profiling of prostate carcinomas with increasing tumor stage by deep sequencing.

Hart M, Nolte E, Wach S, Szczyrba J, Taubert H, Rau TT, Hartmann A, Grässer FA, Wullich B.

Mol Cancer Res. 2014 Feb;12(2):250-63. doi: 10.1158/1541-7786.MCR-13-0230. Epub 2013 Dec 13.

19.

Cryogenic measurements of mechanical loss of high-reflectivity coating and estimation of thermal noise.

Granata M, Craig K, Cagnoli G, Carcy C, Cunningham W, Degallaix J, Flaminio R, Forest D, Hart M, Hennig JS, Hough J, MacLaren I, Martin IW, Michel C, Morgado N, Otmani S, Pinard L, Rowan S.

Opt Lett. 2013 Dec 15;38(24):5268-71. doi: 10.1364/OL.38.005268.

PMID:
24322234
20.

The proto-oncogene ERG is a target of microRNA miR-145 in prostate cancer.

Hart M, Wach S, Nolte E, Szczyrba J, Menon R, Taubert H, Hartmann A, Stoehr R, Wieland W, Grässer FA, Wullich B.

FEBS J. 2013 May;280(9):2105-16. doi: 10.1111/febs.12236. Epub 2013 Apr 8.

Supplemental Content

Loading ...
Support Center